We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CAR T Cell Therapy Shows Promise in Acute Myeloid Leukemia

News   May 10, 2018 | Original story from Moffitt Cancer Centre

 
CAR T Cell Therapy Shows Promise in Acute Myeloid Leukemia

Relapsed AML patient treated with CYAD-01 CAR-T therapy. CD34 IHC of the core biopsy shows clusters of blasts (~7%) consistent with relapsed disease (Panel A). Prominent dysmegakaryopoiesis was also noted (Panel B). BM biopsy at day +56 following 3 infusions of CYAD-01 showed normal trilineage hematopoiesis with CD34 IHC showing no increase in blasts (Panel C). Patient also with significant improvement of hematopoiesis as transfusion independent with marked increase of hemoglobin and platelet count (Panel D). Credit: doi:10.3324/haematol.2017.186742

 
 
 

RELATED ARTICLES

Boy With Rare Brain Tumor One of First in UK to Receive Proton Beam Therapy Treatment

News

A 15-year old from West Sussex, diagnosed with a brain tumor last August, will become one of the first patients in the UK to receive state-of-the-art proton beam therapy treatment at a new £125 million center opened in Manchester.

READ MORE

Swallowing This Special Sponge Enables Esophageal Cancer Detection

News

Swallowing a small capsule attached to a long string could be the way forward in detecting esophogeal cancer.

READ MORE

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE